Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law 2026 FDA Peptide Reclassification Purefico Medspa and Therapy The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification